UC WAR. CALL 03/25 VWSB/ DE000HD43MG6 /
| 2024-05-23 9:46:50 PM | Chg.+0.0400 | Bid9:59:45 PM | Ask9:59:45 PM | Underlying | Strike price | Expiration date | Option type |
|---|---|---|---|---|---|---|---|
| 0.9900EUR | +4.21% | 0.9000 Bid Size: 4,000 |
1.0300 Ask Size: 4,000 |
VESTAS WIND SYS. DK ... | 300.00 - | 2025-03-19 | Call |
GlobeNewswire
11:30 PM
Elicio Therapeutics Announces Preliminary Data from the Ongoing AMPLIFY-7P Phase 1a Study of ELI-002...
GlobeNewswire
11:29 PM
ALT Stockholders: Robbins LLP Reminds ALT Stockholders of Securities Fraud Class Action Against Alti...
GlobeNewswire
11:25 PM
MTTR Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Sale of Matterport to CoSta...
GlobeNewswire
11:23 PM
DOCS INVESTOR NEWS: ROSEN, TRUSTED NATIONAL TRIAL COUNSEL, Encourages Doximity, Inc. Investors to Se...
GlobeNewswire
11:22 PM
HRBR Stockholders: Robbins LLP Reminds HRBR Stockholders of Securities Fraud Class Action Against Ha...
GlobeNewswire
11:21 PM
INTC Stockholders: Robbins LLP Reminds INTC Stockholders of Securities Fraud Class Action Against In...
GlobeNewswire
11:18 PM
Fresh2 Group Ltd. Announces Receipt of a Delinquency Compliance Alert Notice from Nasdaq
Newsfile Corp
11:15 PM
American Aires Extends Global Expansion by Opening Latest International Fulfillment Center in the UK
GlobeNewswire
11:15 PM
Kronos Bio to Present Clinical Update on Phase 1/2 Trial of KB-0742 at the 2024 American Society of ...
GlobeNewswire
11:13 PM
SpringWorks Therapeutics Announces Data to be Presented at the 2024 American Society of Clinical Onc...
GlobeNewswire
11:10 PM
Sensei Biotherapeutics Presents Promising Clinical Data from Phase 1 Dose Escalation Study of SNS-10...
GlobeNewswire
11:09 PM
Ivy Brain Tumor Center announces Phase 0/2 clinical readout of niraparib indicating significant impr...
GlobeNewswire
11:06 PM
G1 Therapeutics Announces Upcoming Presentation at the 2024 American Society of Clinical Oncology (A...
GlobeNewswire
11:05 PM
Updated Phase 1 Clinical Data for SYS-6002 (CRB-701) to be presented at 2024 ASCO Annual Meeting
GlobeNewswire
11:05 PM
BioAtla Presenting Phase 1 Evalstotug Clinical Trial Data Demonstrating Clinical Benefit at the Upco...
GlobeNewswire
11:05 PM
I-Mab Announces Encouraging Phase 1 Clinical Data of PD-L1x4-1BB Bispecific Antibody Ragistomig at A...
GlobeNewswire
11:05 PM
Compass Therapeutics to Present Phase 1 Data for CTX-471, A Novel CD137 Agonist Antibody, Demonstrat...
GlobeNewswire
11:05 PM
FibroGen Announces Presentation of Positive Interim Data from the Phase 1b Study of FG-3246 (FOR46) ...
GlobeNewswire
11:05 PM
NKGen Biotech Publishes Phase 1 Interim Analysis Results of SNK02 Allogeneic NK Cell Therapy in Adva...
